Introduction:
Type 1 diabetes mellitus (T1DM) development is influenced by both genetic and environmental factors [1] . The incidence of T1DM has significantly increased worldwide [2] [3] [4] [5] [6] [7] and environmental factors are thought to play a critical role in this. Innate immunity protects hosts from bacterial invasion by recognizing bacterial components through their pattern recognition receptors (PRRs). These PRRs include Toll-like receptors (TLRs) and nucleotide-binding oligomerization domain-like receptors (NOD-like receptors, NLRs). Interestingly, TLR deficiencies on the Non-Obese Diabetic (NOD) mouse background both increase susceptibility to and protect from T1DM [8] [9] [10] [11] [12] [13] . Deficiency in MyD88, an adaptor protein that mediates most TLR signaling, induced complete protection from T1DM, which was abolished when MyD88 -/-NOD mice were housed in germ-free (GF)
conditions [14] . Therefore, interactions between the TLR family and gut microbiota regulate T1DM development. However, much less is known about the role of NLR family members in T1DM susceptibility, in humans and mice. We recently reported that NLRP3, an important inflammasome component, influences T1DM development by regulating chemokines and their receptors in both immune cells and islet beta cells, preventing immune cell migration to the targeted tissue [15] .
Nucleotide-binding oligomerization domain-containing protein 2 (Nod2) is a cytosolic bacterial sensor of muramyl dipeptide that induces antimicrobial peptide release and inflammatory signaling required for maintenance of the homeostasis of gut microbiota [16] [17] [18] . Nod2 mutations are associated with high susceptibility to Crohn's disease, a common inflammatory disorder of the bowel [19, 20] . Furthermore, Nod2 deficiency in mice correlates with increased bacterial susceptibility [16, 21] . To investigate the role of Nod2 in a T1DM model, we generated NOD mice deficient in Nod2 (Nod2 -/-NOD). We hypothesized that Nod2 modulates T1DM development by regulating the composition of gut microbiota, which alters the immune cell function. Our results fully supported our hypothesis and raise an important point about alteration of immunological phenotype by housing conditions.
Materials and methods

Mice
NOD/Caj mice have been maintained at Yale University for approximately 30 years.
Nod2
-/-B6 mice [16] were obtained from the Jackson Laboratory. They were backcrossed to NOD mice for 10 generations and the purity of the NOD genetic background was further confirmed by mouse genome scan (DartMouse). The mice were housed in specific pathogen-free (SPF) or germ-free (GF) conditions in a 12-hour dark/light cycle. All mice received irradiated food ad libitum and were housed in individually-ventilated filter cages (SPF) or open-topped cages within a gnotobiotic isolator (GF). Three types of experimental breeding and four types of experimental housing strategies were applied in this study as summarized in Supplementary 
Natural history of diabetes development
Female Nod2 -/-NOD and Nod2 +/+ NOD mice were assessed weekly for glycosuria for 30 weeks. Diabetes was confirmed by blood glucose of ≥250 mg/dL (≥13.9 mmol/L).
Short term and long term co-housing
Three to 4-week-old female Nod2 -/-NOD or Nod2 +/+ NOD littermates were divided into groups, whereby Nod2 +/+ NOD and Nod2 -/-NOD mice were housed in separate groups or co-housed in cages where the genotypes were mixed. Experiments were terminated when the mice were aged 9-10 weeks or 30 weeks old.
Histopathology and insulitis
Pancreata from 12-week old female mice were fixed in 10% buffered formalin and embedded in paraffin. Tissues were sectioned and stained with hematoxylin and eosin. Insulitis was scored under light microscopy with the following grading scale: 0, no insulitis; I, infiltration ＜25% of the islet; II, 25-75% infiltration; III, >75% infiltration. A range of 170-212 islets were scored for insulitis in each group (n = 7-8 mice). Significance was determined using a Chi square test. ** p<0.01.
Extraction of gut bacterial DNA
Fecal samples from female Nod2 -/-NOD and Nod2 +/+ NOD mice were collected from 12-week old mice and resuspended in 300µl TE buffer containing 0.5% SDS and 200µg/ml Proteinase K. Bacterial DNA was extracted as previously described [22] .
16S rRNA sequencing and microbiota classification
The V4 region of the 16S rRNA gene was amplified from each DNA sample using a bar-coded broadly-conserved bacterial forward (5'-GTGCCAGCMGCCGCGGTAA-3') and reverse primer (5'-GGACTACHVGGGTWTCTAAT-3').
The PCR products were purified using a Qiagen gel extraction kit. The DNA concentration was quantified and equimolar amounts of each sample were pooled and used for pyrosequencing with the Ion Torrent PGM sequencing system (Life Technologies). The sequencing data were analyzed with the QIIME software package and UPARSE pipeline to pick operational taxonomic units (OTUs). Taxonomy assignment was performed using representative sequences of each OTU. Beta-diversity was calculated to compare differences between microbial communities, shown as Principal Coordinate Analysis (PCoA).
Quantitative real-time PCR (qPCR)
Quantitative real-time PCR (qPCR) was performed using Bio-Rad iQ5 qPCR detection system according to the manufacturer's instructions. The relative mRNA level of segmented filamentous bacteria (SFB) was determined using the 2-ΔΔCt method and normalization using the 16S rRNA values with SFB specific primers (forward primer:
5'-AGGAGGAGTCTGCGGCACATTAGC-3' and reverse primer:
5'-TCCCCACTGCTGCCTCCCGTAG-3').
Gut lumen IgA detection
Gut contents were collected from Nod2 +/+ NOD and Nod2 -/-NOD mice at 12 weeks of age by flushing the small intestine with 10 mls of sterile PBS. The gut flush was then centrifuged (2000 rpm, 5mins, RT) and the supernatant was collected for IgA detection using ELISA (Southern Biotech) following the protocol described by Harriman et al [23] .
Interaction of gut bacteria and immune cells in co-culture with splenocytes.
The large intestine was harvested from 2-month old female Nod2 -/-NOD and
Nod2
+/+ NOD mice and flushed with 5 mls of sterile PBS. The gut contents were vortexed for 2 mins followed by centrifuging for 5 mins at low speed (52xg) to remove dietary residue. The supernatant was transferred to a new tube and spun. After washing the pellet twice more, the combined supernatant was centrifuged at 469xg to remove mammalian cells. Bacteria in the supernatant were pelleted by centrifugation at high speed (1876xg, 5mins) and resuspended in PBS. Bacterial concentration was measured with a spectrophotometer (Bio-Rad) and heat-inactivated at 90℃ for 20 mins. 10 8 heat-inactivated bacteria were co-cultured with splenocytes (2x10 6 /ml) from Nod2 -/-NOD or Nod2 +/+ NOD mice for 14 hours prior to ICC.
Oral Gavage
Fresh fecal pellets were harvested from 4-5 week old Nod2 +/+ NOD or Nod2 -/-NOD mice housed separately. Pellets were homogenized and gently centrifuged to remove large particles (1xg, 10 minutes). OD values were used to determine bacterial colony forming units (CFU). Germ-free WT NOD mice were then colonized with 2x10 8 CFU by oral gavage, and terminated for experiments 2-3 weeks after gavage. Successful colonization was evaluated by 16S rRNA bacterial sequencing of fecal pellets from the ex-GF mice. 
Antibodies and reagents
Cell surface and Intracellular cytokine (ICC) staining
Cells were stimulated with PMA (50ng/ml, Sigma) and ionomycin (500ng/ml, Sigma)
in the presence of 1µl GolgiPlug TM (BD) at 5x10 6 /ml in cell culture medium for 4.5 hours.
Fc receptors were blocked using the Fc-blocking antibody (incubated at 4°C for 15mins), then the cells were stained (30mins at 4°C) with surface markers and viability dye. The cells were then washed prior to fixation (20mins at RT) and permeabilization, using were collected on day 4 prior to 3 H-thymidine addition for the last 18 hours of the 5-day culture to assess proliferation.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 7 software. Diabetes incidence was compared using log-rank test. In vitro assays were analyzed with Student's t test or ANOVA and P<0.05 was considered significant.
Results：
T1DM incidence in Nod2-deficient NOD mice was dependent on housing status
We set up three independent observation groups (summarized in Supplemental Table   1 1D ). These results suggested that the gut microbiota affected T1DM development.
Diabetes susceptibility is modulated by altered gut microbiota in Nod2-deficient
NOD mice
We conducted further studies using non-littermate mice (from Nod2 -/-NOD breeding or Nod2 +/+ NOD breeding) that were housed together (cohoused) or separately (non-cohoused) at weaning. We specifically did not use Nod2 -/-and Nod2 +/+ littermates in order to study how distinct microbiota, shaped by Nod2, influence the immune responses.
To verify whether gut microbiota were responsible for modifying T1DM susceptibility, we collected fresh fecal samples from pre-diabetic female Nod2 -/-NOD and Nod2 +/+ NOD mice and conducted 16S rRNA sequencing. Principal component analysis (PCA) revealed that the composition of gut microbiota from Nod2 -/-NOD mice was very different from Nod2 +/+ NOD mice when they were not cohoused (Fig. 2A) ; however, this difference was eliminated upon cohousing the mice (Fig. 2B) . We further evaluated changes of the microbiota composition at 3 weeks (before housing changes) and at 8-9 weeks of age (non-cohoused and cohoused). Interestingly, the gut microbiota composition was dramatically altered in Nod2 -/-NOD mice when cohoused compared to non-cohoused
Nod2
-/-NOD mice, with the latter similar to the microbiota composition they had at 3 weeks whereas the former were indistinguishable from the microbiota composition of Fig. 1A ). Interestingly, Nod2 +/+ NOD mice also had a change in their microbiota when they were cohoused or non-cohoused, although the change was much more subtle. This, however, suggests that the subtle changes in the microbiota of Nod2-sufficient mice over time may protect the mice from developing diabetes (Fig. 1C ).
We identified that Candidatus Arthromitus and Ruminococcus, which are of the phylum Firmicutes, and Adlercreutzia, of the phylum Actinobacteria, were significantly increased in cohoused Nod2 -/-NOD mice compared with non-cohoused Nod2 -/-NOD mice Nod2-deficiency has been shown to reduce the level of antimicrobial peptides (AMPs) and thus alter the gut microbiota in other models [16, 18] . Therefore, we investigated whether AMPs contribute to the altered gut microbiota composition in Nod2 -/-NOD and Nod2 +/+ NOD mice, both cohoused and non-cohoused. As expected, non-cohoused
-/-NOD mice had reduced levels of AMPs (particularly Reg3β) compared to non-cohoused Nod2 +/+ NOD mice (Supplemental Fig. 1B-D) . Further, cohousing significantly increased AMP levels, as others have previously reported [24] . This suggests that alterations in AMP expression were at least partly responsible for the altered microbiota.
Effect of Nod2 on macrophages (Mφ) and dendritic cells (DCs)
We next examined the phenotype of the immune cells from cohoused and non-cohoused mice. As antigen presenting cells (APCs), especially Mφ and DCs, are able to take up and present antigens from the gut lumen [25, 26] Fig 2C) .
These results suggest that the Mφ and DCs are not responsible for altered Nod2-mediated spontaneous diabetes susceptibility, unlike the streptozotocin-induced model [27] . (Fig. 3A) , co-housing led to a significant increase of IgA-producing B-cells in PPs of Nod2 -/-NOD mice. A similar trend was also seen in cohoused Nod2 +/+ NOD mice (Fig. 3A ). An increase in secreted IgA was also detected in the small intestine (Fig. 3B ). This suggests that the cohousing induced altered gut microbiota, which in turn promoted mucosal B-cell responses, whereas in the steady state of gut microbiota, IgA-producing mucosal B-cells were not affected by Nod2.
Effect of Nod2 on mucosal B-cells
PP-residing IgG2b-expressing B-cells were also influenced by cohousing, as non co-housed
Nod2 -/-NOD mice had lower levels of IgG2b-expressing B-cells compared to co-housed
Nod2
-/-NOD mice (Fig. 3C) . Further, IgG1-expressing B-cells were increased in CH WT Nod2 +/+ NOD mice when compared to CH Nod2 -/-NOD mice within the PP (Fig. 3D ).
Together, these data suggest that the altered microbiota induced by cohousing affect the mucosal antibody responses.
Effect of Nod2 on T-cells
To investigate if Nod2 affects T-cell function, we examined cytokine expression of T-cells from spleen, PLN and PPs. We found that, in the absence of Nod2, co-housing led to a significant increase of IFNγ-producing CD8 + T-cells in PPs of Nod2 -/-NOD mice compared with non-cohoused Nod2 -/-NOD or cohoused Nod2 +/+ NOD mice (Fig. 4A ).
Interestingly, a lower percentage of splenic IL-17A-producing CD4 + T-cells was seen in
Nod2
-/-NOD mice whereas co-housing significantly increased the percentage of IL-17A-producing CD4 + T-cells in PLN and PPs of Nod2 -/-NOD mice compared with non-cohoused Nod2 -/-NOD or Nod2 +/+ NOD mice (Fig. 4B) . SFB have been shown to induce IL17-expressing T cells [28] . Interestingly, the CD4 + IL17a + T cells showed a similar pattern to the level of SFB detected (Fig 2H) , particularly splenic CD4 + IL17a + T cells (Fig. 4B) . The increased proportion of IL17-expressing CD4 + T cells in both the PLN and PP from cohoused Nod2 -/-NOD mice that had increased diabetes suggests that other microbiota are capable of inducing IL17 in CD4 T cells.
Next we investigated whether housing conditions affect Tregs. We found proportional changes in CD4 + CD25 + FoxP3 + T-cells predominantly in the PLNs (Fig. 5A and B). Interestingly, the Nod2 +/+ NOD mice housed separately, which have the highest incidence of diabetes, had the lowest proportion of Tregs. Further, the Nod2 +/+ NOD co-housed with Nod2 -/-NOD mice (which reduced diabetes onset) or the Nod2 -/-NOD mice housed separately (which have the lowest incidence of diabetes), had the highest proportions of Tregs. Our results suggested a role of the gut microbiota in inducing Tregs (Fig. 5A ).
To assess Treg function, we performed suppression assays using MLRs, in which T-cells from C57BL/6 mice (responders) were co-cultured with mitomycin-c treated NOD APCs (Fig.   5D ). Similar results were seen in an autoantigen-specific Treg suppression assay (data not shown).
Direct effect of gut microbiota on T-cell function
To confirm if the housing-dependent change in gut microbiota was responsible for the different immune responses in the Nod2 -/-NOD mice, we stimulated splenocytes from 2-month old female Nod2 -/-NOD and Nod2 +/+ NOD mice with heat-inactivated colonic bacteria of Nod2 -/-NOD or Nod2 +/+ NOD mice. Similar to the ICC staining shown (Fig. 4) , there was a significant reduction of IFN-γ producing CD8 + T-cells from Nod2 -/-NOD mice when compared to Nod2 +/+ NOD mice, in response to gut bacteria from either Nod2-deficient or sufficient mice (Fig. 6A) . However, gut bacteria from Nod2 +/+ NOD mice induced a greater IFN-γ production from CD8 + T-cells from Nod2 -/-NOD or Nod2 +/+ NOD mice (Fig.   6A ), indicating that gut bacteria from Nod2 +/+ NOD mice are more inflammatory.
Interestingly, the gut bacteria, regardless of the donor, appeared to suppress IL-17A-producing CD4 + T-cells (Fig. 6B ) and we did not find direct effects of gut bacteria on TNF-α or IL-10-producing T-cells in vitro (data not shown).
Taken together, our results suggest Nod2 -/-NOD mice had a distinct gut microbiota composition compared with Nod2 +/+ NOD mice, and that the variance in components of gut microbiota altered the immune cell function which modulates T1DM susceptibility.
To further prove the concept, we colonized germ-free (GF) NOD mice with feces from 4-5 week old Nod2 -/-NOD or Nod2 +/+ NOD mice that were housed separately. We studied the ex-GF mice 2-3 weeks after introduction of gut bacteria. 16S rRNA sequencing results showed a clear separation in the recipients depending on the donor microbiota they received (Fig. 7A) . Interestingly, we found increased cecal weight in the ex-GF mice given
Nod2
-/-NOD feces (Supplemental Fig. 3A ) and the small intestine was also longer (data not shown), neither of which were observed in SPF Nod2 -/-NOD mice (data not shown). We also found reduced inflammatory cytokine-producing B cells, T cells in PLNs of ex-GF mice colonized with Nod2 -/-NOD fecal bacteria (Fig. 7B ). In line with the reduction of inflammatory cytokine production by immune cells, these mice also had a higher frequency and absolute number of CD4 + CD25 + FoxP3 + Treg cells in the mesenteric lymph nodes (MLNs) and PPs compared to their counterparts colonized with Nod2 +/+ NOD fecal bacteria ( Fig. 7C-E ).
There were no changes in phenotype and cytokine production in DCs or Mφ in the ex-GF mice (data not shown). However, given the results of the changes in IgA + B-cells in cohoused SPF Nod2 -/-NOD mice and altered cytokine production in the ex-GF mice colonized with Nod2 -/-NOD fecal bacteria ( Fig. 3 and 7B), we tested islet-specific APC Fig. 3B-C) . Taken together, we provide evidence that Nod2 alters the composition of gut microbiota, which in turn modulate the adaptive immune system and influence diabetes susceptibility.
Discussion:
Our study sought to understand the role Nod2 plays in the development of spontaneous T1DM susceptibility. Our key finding was that Nod2-mediated T1DM susceptibility was dependent on the composition of the gut microbiota, which could be influenced by the housing of Nod2-deficient or sufficient NOD mice. The Nod2-deficient NOD mice were protected from T1DM development, if they were housed only with Nod2-deficient NOD mice. However, the disease protection was diminished if they were housed with Nod2-sufficient littermates. Conversely, the higher incidence of the Nod2-sufficient NOD mice was reduced when these mice were housed with their Nod2-deficient NOD littermates, emphasizing the importance of gut bacteria in influencing diabetes incidence. This was further confirmed by housing Nod2-deficient mice with Nod2-sufficient non-littermate mice.
Although Nod2 deficiency led to a distinctive community of gut microbiota in NOD mice, its effect on diabetes was masked by the dominant community from Nod2-sufficient mice when cohoused. Thus, one of the roles of the Nod2 gene in T1DM development was to alter the gut microbiota. While macrophages and DCs were unaffected by Nod2 deficiency, the phenotype and functions of T-and B-cells were altered, some of which was likely to be related to the gut microbiota composition. This suggests that Nod2 activation is important for mediating changes in the gut microbiota, which affects the adaptive immune cells and subsequently diabetes development.
We recently showed that NLRP3 alters T1DM development by limiting the recruitment and infiltration of autoreactive CD4 + T-cells into the pancreas [15] . Our current study provides evidence that NLR signaling is important for modulating diabetes susceptibility by alteration of the microbial composition, which in turn affects the phenotype and functions of immune cells. Furthermore, this study demonstrates that the Nod2 gene effect on T1DM
susceptibility is due to altering the composition of gut microbiota, and diabetes protection in 
Nod2
-/-NOD mice, in which diabetes development was significantly reduced; iii) reconstitution of gut microbiota from Nod2 -/-NOD or Nod2 +/+ NOD to germ-free NOD mice.
The diabetes incidence differences in Nod2 -/-NOD mice, when living with different housing partners, strongly supports the role of gut microbiota. We found a distinct profile of the gut microbiota between Nod2 -/-NOD and Nod2 +/+ NOD mice when they are housed separately, which correlated with diabetes development. It is known that Nod2 is important for the expression of antimicrobial peptides and in controlling the expansion of intestinal bacteria [16, 18] . In line with those reports, we found Nod2-deficient NOD mice expressed reduced levels of antimicrobial peptides; however, upon cohousing with Nod2-sufficient NOD mice, the levels of AMPs were increased. This suggests that the secretion of antimicrobial peptides is gut microbiota-dependent but can be independent of Nod2, as others have reported [24] . Therefore, the alterations of gut microbiota composition in the Nod2 -/-NOD mice, caused by cohousing with Nod2 +/+ NOD mice, induce a large increase in AMP synthesis to similar levels seen in the Nod2-sufficient mice, thereby, diminishing diabetes protection in Nod2-deficient mice.
Interestingly, Nod2 deficiency had no effect on professional APCs, such as macrophages or DCs. However, the APC function of B-cells was attenuated in the absence of Nod2 or in the presence of Nod2 -/-NOD gut microbiota. Nod2 deficiency also altered
IgA-producing B-cells. It is well documented that a large amount of IgA is secreted into the gut lumen to protect the host from microbial invasion [29] [30] [31] . In Nod2 deficiency, a mild reduction of secreted IgA in gut lumen was observed; however, cohousing with have an intimate relationship with gut mucosal immunity. Turley has reported that PLNs drain antigens from both pancreas and intestine [32] . In line with this observation, we recently found a commensal microbial antigen that can be recognized by diabetogenic T cells, which in turn attack islet beta cells [33] . Similar results were also observed in an autoimmune uveitis model [34] . It is conceivable that Nod2 -/-NOD mice harbor less diabetogenic gut microbiota, and thereby have a lower frequency of proinflammatory cytokine-producing T-cells but a higher frequency of Treg cells in PLNs. However, more immunostimulatory gut microbiota were present in Nod2 -/-NOD mice after cohousing with WT mice, which led to a higher frequency of proinflammatory cytokine-producing T-cells and increased disease onset. The proof of concept using GF mice confirmed our hypothesis.
Costa reported recently that Nod2 is important in streptozotocin-induced diabetes in C57BL/6 mice [27] . Although both our study and theirs demonstrated increased Tregs in response to Nod2 -/-microbiota, the cause of the Treg increase in the two model systems was different. In our spontaneous T1DM model, gut microbiota affected by housing status, regulated the change of Tregs; however, the anti-inflammatory cytokine IL-10 production was regulated by Nod2 gene expression (or lack of expression) but independent of housing conditions. While Costa and colleagues showed that CD11b + CD11c + cells were important for mediating suppression and diabetes protection in their streptozotocin-induced disease model, we did not observe any changes in both phenotype and function of DCs or macrophages in vitro and in vivo. The changes we observed were in the B and T-cells in our spontaneous diabetes model. The discrepancy between the two studies was most likely due to the two very different model systems, streptozotocin-induced diabetes and spontaneous T1DM. More importantly, the two studies also used two very different mouse strains with different genetic backgrounds, C57BL/6 vs NOD.
Our study also raises a very important issue of housing conditions in interpretation of the disease phenotype in a genetically-targeted mouse strain. We propose that the phenotype should be tested in two housing conditions -cohousing with gene-sufficient littermates and housing separately from gene-sufficient mice. If the disease phenotype is affected by the housing conditions when housed separately, as in our study, but not when cohoused, it suggests that the change in the gut microbiota is an integral part of the effect exerted by the specific gene.
Although the mouse Nod2 protein shares high homology with human Nod2 protein [35] , it is not known if Nod2 has genetic associations with human T1D. However, a recent study suggests a high prevalence of inflammatory bowel disease (IBD) in patients with T1D
[36]. It is not clear whether the patients developed IBD first or T1D first; however, Nod2 is a major susceptibility gene for IBD [19, 20] and Nod2 plays an important role in mediating microbial signaling responses. It is possible that activation of Nod2 pathway may be context-dependent in individuals with T1D, i.e., dependent on microbial exposure, as we found in NOD mice.
In conclusion, our data suggest that Nod2 plays a role in T1DM development.
Unlike inflammatory bowel disease, where the Nod2 gene plays a dominant role in the disease development, in T1DM, the role of the Nod2 gene contributes to alteration of the gut microbiota, but this effect can be over-ridden by altering the housing conditions. Thus, Nod2 acts as a recessive modulator in T1DM susceptibility. Finally, as human T1D
incidence is increasing, this adds further weight to the increased importance of environmental factors in human studies. shown for non-cohoused ( Fig. 2A) and cohoused (Fig. 2B) mice. The composition of gut microbiota was compared at genus level between Nod2 -/-NOD and Nod2 +/+ NOD mice (n=6 each) which were cohoused (CH) or non-cohoused (NCH) (Fig. 2C-G) . The abundance of SFB in the gut microbiota was assessed by qPCR with SFB specific primers (Fig. 2H ).
Author Contributions
The level of SFB expression was calculated by the delta-delta threshold cycle method after normalization with bacterial 16S rRNA. Each sample was plated in triplicate and the experiments were repeated twice. Student's t test was used for statistical analysis (*P<0.05; **P<0.001). Error bars represent SEM. The data represent at least 3 independent experiments (n=3-4/group/experiment).
Student's t test was used for statistical analysis. *P<0.05; **P<0.001; *** P<0.0001. Error bars represent SEM. 
Nod2
-/-NOD or Nod2 -+/+ NOD mice. Bacterial DNA was extracted from fecal pellets from WT or KO gavaged ex-GF NOD mice (n=7/group) and the original bacteria donors.
Pyrosequencing was conducted using the Ion Torrent PGM sequencing system. The sequencing data were analyzed with QIIME software package and UPARSE pipeline to pick operational taxonomic units (OTUs 
+/+ NOD female mice (cohoused and non-cohoused) was used to generate cDNA.
QPCR was then conducted for the antimicrobial peptides (Reg3γ, Reg3β and RelmB).
Samples were compared to GAPDH and fold change was generated from ΔΔCT values.
Statistical analysis was performed using Student t test; *P<0.05 or **P<0.01. 
